InVitria Showcases Exbumin and Optibumin 25 at IPEC Excipient World: Biologics Summit
FOR IMMEDIATE RELEASE Junction City, KS – April 29, 2026 – InVitria, a global leader in chemically defined, animal origin free recombinant proteins for biologics manufacturing, today announced its participation in the IPEC Excipient World Biologics Summit, taking place May 4-6, 2026 in Nashville, TN. The company will highlight its recombinant human serum albumin (rHSA) portfolio, designed to enhance formulation stability, consistency, and performance in injectable biologics, vaccines, …